- Home
- CPBI vs CLSD Comparison
CPBI vs CLSD Comparison
Compare CPBI & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- CLSD
- Stock Information
- Founded
- CPBI 2023
- CLSD 2011
- Country
- CPBI United States
- CLSD United States
- Employees
- CPBI N/A
- CLSD N/A
- Industry
- CPBI
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- CLSD Health Care
- Exchange
- CPBI Nasdaq
- CLSD Nasdaq
- Market Cap
- CPBI 63.0M
- CLSD 68.4M
- IPO Year
- CPBI N/A
- CLSD 2016
- Fundamental
- Price
- CPBI $15.40
- CLSD $0.41
- Analyst Decision
- CPBI
- CLSD Hold
- Analyst Count
- CPBI 0
- CLSD 4
- Target Price
- CPBI N/A
- CLSD $4.33
- AVG Volume (30 Days)
- CPBI 6.6K
- CLSD 780.5K
- Earning Date
- CPBI 01-01-0001
- CLSD 08-08-2025
- Dividend Yield
- CPBI N/A
- CLSD N/A
- EPS Growth
- CPBI 0.69
- CLSD N/A
- EPS
- CPBI 0.98
- CLSD N/A
- Revenue
- CPBI $19,464,000.00
- CLSD $4,166,000.00
- Revenue This Year
- CPBI N/A
- CLSD $78.37
- Revenue Next Year
- CPBI N/A
- CLSD $17.79
- P/E Ratio
- CPBI $15.72
- CLSD N/A
- Revenue Growth
- CPBI 9.30
- CLSD N/A
- 52 Week Low
- CPBI $11.51
- CLSD $0.29
- 52 Week High
- CPBI $15.68
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- CPBI 57.47
- CLSD 39.24
- Support Level
- CPBI $15.10
- CLSD $0.39
- Resistance Level
- CPBI $15.68
- CLSD $0.44
- Average True Range (ATR)
- CPBI 0.08
- CLSD 0.04
- MACD
- CPBI -0.00
- CLSD 0.01
- Stochastic Oscillator
- CPBI 51.72
- CLSD 36.73
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.